🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07163819
Recruiting Phase 2

Effect of Probiotic Intervention on Travel-Related Health Conditions During Short-Term Overseas Travel

NCT07163819 · tracked via the Priya Life Science China tracker
Sponsor
Universiti Sains Malaysia
Phase
Phase 2
Started
2025-07-31
Last updated
2025-09-17

Condition(s) studied

Healthy Adults

Investigational drug(s) / intervention(s)

ProbioticPlacebo

Probiotic: Daily 6-drops of Bifidobacterium longum subsp. infantis M-63, B. breve M-16V, and B. longum BB536 in non-GMO corn starch as excipient, in medium-chain triglyceride oil (1.5 × 109 CFU/day)

Placebo: Daily 6-drops of non-GMO corn starch in medium-chain triglyceride oil

Study summary

International travel disrupts gut health through dietary changes, microbial exposure, and stress, often causing gastrointestinal symptoms like traveler's diarrhea and sleep disturbances. These shifts may increase antibiotic resistance risks. Probiotics may help stabilize gut microbiota and improve well-being during travel. This randomized, double-blind, placebo-controlled trial investigated whether probiotic supplementation mitigates gut microbiota perturbations, gastrointestinal symptoms, and sleep issues in adults traveling abroad. The investigators also assessed changes in anxiety, well-being, gut immunity, microbial function, and antibiotic resistance genes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Generally healthy adults * Scheduled to undertake a short-term round trip (less than 7 days) to abroad * Able to complete study procedures * Willing to take intervention products Exclusion Criteria: * Use of antibiotics, probiotics, hormones, immunosuppressants, biologics or JAK inhibitors within four weeks prior to study * Chronic or severe systemic diseases (including cardiovascular, hepatic, renal, malignant or psychiatric disorders) * Uncontrolled parasitic infections * Long-term use of corticosteroids, growth hormone, vitamin B12, lysine or inositol * Major surgery within one month * Allergy to probiotic components * Other conditions deemed inappropriate by investigators

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Tsinghua University Science and Technology Haidian Beijing Municipality Recruiting
Universiti Sains Malaysia George Town Pulau Pinang Not Yet Recruiting

More Universiti Sains Malaysia trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07163819 on ClinicalTrials.gov ↗ ← All trials in China